EUVIMEDScopri EUVIMED
Open access · CC BY-NC 3.0

Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment

Janviere Kabagwira, Ryan N Fuller iD, Paul A Vallejos, Chase S Sugiono, Vola-Masoandro Andrianarijaona, Jazmine Brianna Chism, Michael P O'Leary, David Caba Molina, William Langridge, Maheswari Senthil, Nathan R Wall iD

OncoTargets and Therapy · 2024-01 · Volume 17 · 63-78

DOI: 10.2147/ott.s448024 ↗

At a glance

Journal article in OncoTargets and Therapy, 2024-01. Written by Janviere Kabagwira and 10 co-authors. Institution: Department of Basic Science, Division of Biochemistry, Loma Linda University, Loma Linda, CA, USA. Cited 4 times so far (Crossref); 82 references. The full text is freely available (open access, CC BY-NC 3.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Introduction

Peritoneal metastases from colorectal cancer (CRC) present a significant clinical challenge with poor prognosis, often unresponsive to systemic chemotherapy. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment approach for select patients. The use of curcumin, a natural compound with antitumor properties, in HIPEC is of interest due to its lower side effects compared to conventional drugs and potential for increased efficacy through direct delivery to the peritoneal cavity.

Methods

An in vitro hyperthermic model was developed to simulate clinical HIPEC conditions. Three colon cancer cell lines (SK-CO-1, COLO205, SNU-C1) representing different genetic mutations (p53, KRAS, BRAF) were treated with either curcumin (25 µM) or mitomycin-C (1 µM) for 1, 2, or 3 hours. Post-treatment, cells were incubated at 37°C (normothermia) or 42°C (hyperthermia). Cell viability and proliferation were assessed at 24, 48 and 72 hours post-treatment using Annexin V/PI, MTT assay, trypan blue exclusion, and Hoffman microscopy.

Results

Hyperthermia significantly enhanced the antitumor efficacy of curcumin, evidenced by a two-fold reduction in cell viability compared to normothermia across all cell lines. In the SNU-C1 cell line, which harbors a p53 mutation, mitomycin-C failed to significantly impact cell viability, unlike curcumin, suggesting mutation-specific differences in treatment response.

Discussion

The findings indicate that hyperthermia augments the antitumor effects of curcumin in vitro, supporting the hypothesis that curcumin could be a more effective HIPEC agent than traditional drugs like mitomycin-C. Mutation-associated differences in response to treatments were observed, particularly in p53 mutant cells. While further studies are needed, these preliminary results suggest that curcumin in HIPEC could represent a novel therapeutic strategy for CRC patients with peritoneal metastases. This approach may offer improved outcomes with fewer side effects, particularly in genetically distinct CRC subtypes.

Subjects

Author keywords

colorectalcurcuminhyperthermicmitomycin-Cperitoneal carcinomatosis

Authors and institutions

  • Department of Basic Science, Division of Biochemistry, Loma Linda University, Loma Linda, CA, USA.
  • Center for Health Disparities and Molecular Medicine, Loma Linda University, Loma Linda, CA, USA.
  • Division of Surgical Oncology, Department of Surgery, Loma Linda University Health, Loma Linda, CA, USA.
  • Division of Surgical Oncology, Department of Surgery, Irvine Medical Center, University of California, Orange, CA, USA.

ORCID profiles: Ryan N Fuller, Nathan R Wall

Cite

APA

Kabagwira, J., Fuller, R. N., Vallejos, P. A., Sugiono, C. S., Andrianarijaona, V. M., Chism, J. B., O'Leary, M. P., Molina, D. C., Langridge, W., Senthil, M., & Wall, N. R. (2024). Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment. OncoTargets and Therapy, Volume 17, 63-78. https://doi.org/10.2147/ott.s448024

Vancouver

Kabagwira J, Fuller RN, Vallejos PA, Sugiono CS, Andrianarijaona VM, Chism JB, et al. Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment. OncoTargets and Therapy. 2024;Volume 17:63-78. doi:10.2147/ott.s448024

BibTeX
@article{Kabagwira2024,
  author = {Kabagwira, Janviere and Fuller, Ryan N and Vallejos, Paul A and Sugiono, Chase S and Andrianarijaona, Vola-Masoandro and Chism, Jazmine Brianna and O'Leary, Michael P and Molina, David Caba and Langridge, William and Senthil, Maheswari and Wall, Nathan R},
  title = {Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment},
  journal = {OncoTargets and Therapy},
  year = {2024},
  volume = {Volume 17},
  pages = {63--78},
  doi = {10.2147/ott.s448024}
}
Start for free →